Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Vet Intern Med ; 24(5): 1048-54, 2010.
Article in English | MEDLINE | ID: mdl-20695990

ABSTRACT

BACKGROUND: Congential extrahepatic portosystemic shunts (EHPSS) are common in dogs. An effective minimally invasive technique for correction of EHPSS could result in reduced morbidity, reduced costs, and reduced hospitalization times. HYPOTHESIS: Use of an intravascular occlusion device can effectively and safely result in acute complete occlusion of EHPSS in dogs. ANIMALS: Seven dogs with naturally occurring EHPSS that presented to the Purdue University Veterinary Teaching Hospital. METHODS: Prospective, clinical trial. The 7 dogs were consecutively enrolled over a 2-year period. Results of serum biochemistry, total serum bile acids, fasting plasma ammonia, abdominal radiography, and ultrasonography suggested the diagnosis of portosystemic shunts in all dogs. Definitive diagnosis of EHPSS was achieved with cranial mesenteric arterial portography and acute occlusion was attempted by the deployment of the Amplatzer vascular plug (AVP). RESULTS: EHPSS were identified in all dogs consisting of 5 portocaval and 2 portoazygous variants; 1/7 dogs (14%) were intolerant to temporary complete occlusion of the EHPSS. Of the remaining 6 dogs, 5 (83%) had complete occlusion of the EHPSS by the AVP. There were no complications and resolution of abnormal clinical signs and laboratory values was achieved in 4/5 (80%) dogs with complete occlusion. CONCLUSIONS AND CLINICAL IMPORTANCE: Intravascular correction of EHPSS by the AVP is a viable option to surgical correction while larger studies will be required to determine the clinical applicability of this procedure in the broader portosystemic shunt population.


Subject(s)
Dog Diseases/congenital , Portal System/abnormalities , Animals , Dog Diseases/surgery , Dogs , Female , Male , Portal System/surgery , Prospective Studies
2.
J Vet Intern Med ; 24(1): 185-91, 2010.
Article in English | MEDLINE | ID: mdl-19912519

ABSTRACT

BACKGROUND: Systemic arterial thromboembolic events are a serious complication of cardiac disease in cats. OBJECTIVES: To determine if enoxaparin induces an antithrombotic effect in cats at a dosage of 1 mg/kg SC q12h and if this antithrombotic effect is predicted by anti-Xa activity. ANIMALS: Fourteen clinically healthy cats were divided into 3 groups: control (4 cats), treated and assessed at 4 hours (5 cats), and treated and assessed at 12 hours (5 cats). METHODS: A venous stasis model was used and the extent of thrombus formation estimated by measuring thrombus weight and accretion of 125I-fibrinogen. Plasma anti-Xa activity was measured in treated cats. RESULTS: There was a significant reduction in thrombus formation in the 4 h group compared with control (median weight, 0.000 versus 0.565mg/mm, P < .01; median % 125I-fibrinogen accretion, 0.0 versus 42.0%, P < .01). There was a reduction in thrombus formation in the 12 h group (median weight, 0.006 mg/mm, P = .09; median % 125I-fibrinogen accretion, 3.83%, P = .09) but this reduction was not significant. The median percent thrombus inhibition for treated cats was 100.0% at 4 hours and 91.4% at 12 hours. Plasma anti-Xa activity was not significantly correlated with thrombus formation. CONCLUSIONS AND CLINICAL IMPORTANCE: This pilot study demonstrates that enoxaparin, when administered at a dosage of 1 mg/kg SC q12h, produces an antithrombotic effect in a venous statsis model in clinically healthy cats. Furthermore, this study demonstrates that anti-Xa activity is a poor predictor of enoxaparin's antithrombotic effect.


Subject(s)
Anticoagulants/therapeutic use , Cat Diseases/prevention & control , Cats , Enoxaparin/therapeutic use , Venous Thrombosis/veterinary , Animals , Enzyme-Linked Immunosorbent Assay , Female , Male , Pilot Projects , Venous Thrombosis/prevention & control
3.
J Cardiovasc Pharmacol ; 36(1): 1-13, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10892654

ABSTRACT

Recent interest in so-called calcium-sensitizing positive inotropic drugs has highlighted the potential problem of a positive effect on force development being offset, at least partially, by the negative effect that many of these drugs have on relaxation. The purpose of this study was to examine the interplay of contraction and relaxation in determining the overall cardiac effect of different positive inotropic drugs. Using a buffer-perfused isolated rabbit heart preparation, we studied four drugs (calcium, dobutamine, EMD 57033, and CGP 48506) that were given at doses sufficient to increase similarly left ventricular pressure-generating capability by approximately 20%. We show that, even though they produce equivalent changes in pressure-generating capability, these four agents produce dissimilar changes in relaxation capability, with dobutamine speeding relaxation, EMD 57033 slowing relaxation, and calcium and CGP 48506 having little effect of relaxation. Similar relative effects were observed for drug-induced changes in the timing of pressure-generation events. These effects combine to produce different drug-induced changes in overall cardiac pump function judged by the relation between cardiac output and heart rate. Dobutamine shifted the maximal cardiac output to a higher heart rate. In contrast, both calcium sensitizers shifted the maximum in cardiac output to a lower heart rate, whereas calcium had no effect. Thus even though positive inotropic drugs may have similar effects on left ventricular pressure generation, the overall benefit of such drugs on ventricular pump function will depend on how the drug also affects ventricular relaxation and ejection capabilities.


Subject(s)
Cardiotonic Agents/pharmacology , Heart Rate/drug effects , Stroke Volume/drug effects , Ventricular Function, Left/drug effects , Animals , Azocines/pharmacology , Calcium/pharmacology , Cardiac Output/drug effects , Cardiac Output/physiology , Dobutamine/pharmacology , Heart Rate/physiology , Male , Quinolines/pharmacology , Rabbits , Stroke Volume/physiology , Thiadiazines/pharmacology , Ventricular Function, Left/physiology
4.
Am J Physiol ; 273(6): H2708-20, 1997 12.
Article in English | MEDLINE | ID: mdl-9435607

ABSTRACT

Because it is not known whether ejection influences the negative effect of the Ca(2+)-sensitizing drugs on ventricular relaxation, we extended our previous analysis of stress-dependent relaxation in isovolumic beats to encompass ejecting beats and evaluated the relationships between both the time of onset of relaxation and the rate of relaxation and wall stress in a broader analysis framework. Furthermore, because the sites of action of the Ca(2+)-sensitizing drugs CGP-48506 and EMD-57033 may be different, and thus CGP-48506 may have fewer adverse effects on resting muscle length or force, we compared these two drugs to test the hypothesis that CGP-48506 would have less effect than EMD-57033 on relaxation in the isolated buffer-perfused rabbit heart. This analysis of stress-dependent relaxation in both ejecting and isovolumic beats readily differentiates between the negative lusitropic effect of 2 x 10(-6) M EMD-57033, the negligible lusitropic effect of 6 x 10(-6) M CGP-48506, and the positive lusitropic effect of 1.25 x 10(-6) M dobutamine. Furthermore, comparison of the effect of the two Ca(2+)-sensitizing drugs in ejecting versus isovolumic contractions shows that CGP-48506 affects relaxation differently in ejecting contractions than it does in isovolumic contractions, whereas EMD-57033 affects relaxation similarly in both ejecting and isovolumic contractions.


Subject(s)
Azocines/pharmacology , Cardiotonic Agents/pharmacology , Dobutamine/pharmacology , Heart/physiology , Models, Cardiovascular , Myocardial Contraction/physiology , Quinolines/pharmacology , Stroke Volume/drug effects , Thiadiazines/pharmacology , Animals , Heart/drug effects , Heart Rate/drug effects , In Vitro Techniques , Male , Mathematics , Myocardial Contraction/drug effects , Rabbits , Regression Analysis , Stroke Volume/physiology , Vasodilation/drug effects
6.
Science ; 172(3986): 936-9, 1971 May 28.
Article in English | MEDLINE | ID: mdl-17816485

ABSTRACT

Electron-transparent sections of the Allende meteorite, a carbonaceous chondrite, have been prepared by ion-thinning and examined by high-voltage (800-kilovolt) transmission electron microscopy. The matrix crystals, mainly olivine, range in size from approximately 5 to approximately 0.01 micrometers; carbon is present as intergranular films of poorly crystalline graphite. The chondrules exhibit extensive radiation damage, a feature lacking in the matrix. In addition, both chondrules and matrix are undeformed and contain negative crystals; submicroscopic exsolution lamellae are present in pyroxenes. Comparison of the substructure in the Allende meteorite with that in the Parnallee meteorite and in lunar and selected terrestrial rocks leads to the conclusion that chondrule irradiation preceded cold accretion during formation of the solar system and that the meteorite has since been undisturbed.

7.
Science ; 157(3795): 1444-7, 1967 Sep 22.
Article in English | MEDLINE | ID: mdl-17819547

ABSTRACT

Annealing of samples of flint under high pressure, after hot-working in the beta-quartz stability field, produced an exceedingly strong concentration of c-axes parallel to the direction of compression. A specimen deformed under identical conditions, but not annealed, exhibited a much weaker orientation. The strength of the annealed orientation rivals that of the remarkable "cube texture" produced by annealing some face-centered cubic metals after extreme reduction by rolling.

SELECTION OF CITATIONS
SEARCH DETAIL
...